NCT00818584View on ClinicalTrials.gov

An Open-Label Study of the Safety and Pharmacokinetics of Repeated-Dose Micafungin in Neonates

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Candida
Interventions
DRUG

Micafungin

IV Administration

Trial Locations (7)

22908

Charlottesville

27710

Durham

35233

Birmingham

40202

Louisville

64108

Kansas City

75390

Dallas

92868

Orange

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY